scanX
Home
Shukra Pharmaceuticals

Shukra Pharmaceuticals

233.30
0.00
(0.00%)
Market Cap
1,021.60
Eps
16.93
PE Ratio (TTM)
70.70
Dividend Yield
0.11
Industry
Healthcare
52 Week High
238.15
52 Week low
35.73
PB Ratio
18.82
Debt to Equity
0.10
Sector
Pharmaceuticals
Add Ratio
Live Chart

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
29.00 %
Net Income Growth
320.45 %
Cash Flow Change
-264.04 %
ROE
84.62 %
ROCE
117.66 %
EBITDA Margin (Avg.)
162.67 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
4
5
5
6
6
12
12
21
60
77
42
Expenses
3
4
4
4
4
10
10
18
54
55
23
EBITDA
1
1
2
2
2
2
2
3
7
22
19
Operating Profit %
-10 %
24 %
29 %
30 %
29 %
13 %
13 %
14 %
9 %
26 %
32 %
Depreciation
1
0
1
1
1
2
2
2
2
2
2
Interest
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
0
0
1
1
1
0
0
1
4
20
16
Tax
0
0
1
0
0
0
-0
0
0
1
2
Net Profit
0
0
1
1
1
0
0
1
4
19
14
EPS in ₹
0.84
0.76
3.21
3.36
2.95
0.23
1.20
4.79
26.21
16.93
12.60
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
18
17
19
24
28
34
36
35
75
78
Fixed Assets
10
10
10
14
16
17
18
18
20
20
Current Assets
7
6
7
8
11
15
16
16
53
56
Capital Work in Progress
2
2
2
2
2
2
2
2
2
2
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
7
6
7
8
11
15
16
16
53
56
Total Liabilities
18
17
19
24
28
34
36
35
75
78
Current Liabilities
1
1
2
3
4
7
7
12
43
14
Non Current Liabilities
4
3
3
6
9
11
13
6
7
6
Total Equity
14
14
15
15
15
15
16
16
25
58
Reserve & Surplus
12
13
13
13
14
14
14
15
21
47
Share Capital
2
2
2
2
2
2
2
2
4
11
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
1
-1
-1
0
-0
0
-0
4
6
Investing Activities
1
-0
-1
-5
-3
-3
-2
-2
-4
-1
Operating Activities
-2
3
-0
1
0
1
1
8
3
-5
Financing Activities
1
-1
0
4
2
2
2
-7
5
12
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Aug 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
49.17 %
49.17 %
49.17 %
49.17 %
49.17 %
49.17 %
49.17 %
49.17 %
50.90 %
50.90 %
50.90 %
50.90 %
50.96 %
50.96 %
50.96 %
50.96 %
50.96 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.80 %
0.80 %
0.80 %
0.80 %
0.80 %
0.80 %
0.80 %
0.80 %
0.11 %
0.11 %
0.11 %
0.11 %
0.11 %
0.11 %
0.11 %
0.11 %
0.11 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
33.02 %
33.02 %
32.90 %
32.86 %
32.83 %
32.81 %
33.00 %
33.06 %
29.14 %
29.10 %
29.11 %
29.14 %
28.94 %
9.79 %
9.19 %
9.25 %
9.41 %
No of Share Holders
9,345
9,345
9,305
9,268
9,239
9,193
9,237
9,234
9,544
9,582
9,600
9,747
10,963
12,974
14,989
16,321
17,844

Dividend History

Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Announcements

Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
15 hours ago
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 And 33 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 As
1 day ago
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. On January 29 2025 Pursuant To Regulation 30 Of SEBI (Listing And Obligations And Disclosure Requirements) Regulations 2015
6 days ago
View more

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,751.55 4,20,255.52 35.94 49,887.20 12.06 9,648 13.77 47.04
Divis Laboratories
6,035.05 1,60,211.62 78.25 8,184.00 0.89 1,600 64.53 59.36
Cipla
1,446.30 1,16,805.22 23.45 26,520.70 14.17 4,155 47.38 49.10
Torrent Pharmaceuticals
3,085.00 1,04,410.42 56.43 10,785.70 11.59 1,656 13.54 34.52
Mankind Pharma
2,521.35 1,04,022.56 51.56 10,615.60 19.57 1,942 -16.38 46.81
Dr Reddys Laboratories
1,223.05 1,02,052.62 18.95 28,905.40 12.36 5,578 1.69 38.90
Zydus Life Science
969.20 97,524.20 22.90 19,831.50 13.82 3,831 14.57 51.14
Lupin
2,125.80 96,978.48 36.66 20,141.50 19.94 1,936 73.53 48.22
Aurobindo Pharma
1,167.00 67,779.55 18.82 29,559.20 17.55 3,169 8.66 45.72
Alkem Laboratories
5,090.35 60,862.77 28.08 12,978.40 9.84 1,812 14.16 42.91

Corporate Action

Technical Indicators

RSI(14)
Overbought
80.86
ATR(14)
Less Volatile
5.28
STOCH(9,6)
Overbought
85.98
STOCH RSI(14)
Oversold
8.17
MACD(12,26)
Bearish
-2.11
ADX(14)
Extremely Strong Trend
81.20
UO(9)
Bearish
64.98
ROC(12)
Uptrend And Accelerating
12.41
WillR(14)
Overbought
-14.00
Bearish
7
Neutral
0
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Price & Volume Screeners
Fundamental Screeners
Candlestick Screeners
Technical Screeners
Intraday Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.